✦ LIBER ✦

Non-neurological and metabolic side effects in the Cost Utility of the Latest Antipsychotics in Schizophrenia Randomised Controlled Trial (CUtLASS-1)

✍ Scribed by Peluso, Michael J.; Lewis, Shôn W.; Barnes, Thomas R.E.; Jones, Peter B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The cutlass study: A pragmatic, multicen

✍ S.W. Lewis; L. Davies; P. Jones; R. Kerwin; T.R.E. Barnes; R.M. Murray; A. Esmai 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

A Randomized Controlled Trial of the Cos

✍ Linda M. Davies; Thomas R. E. Barnes; Peter B. Jones; Shôn Lewis; Fiona Gaughran 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 306 KB

Effectiveness and cost-effectiveness of

✍ Stefan Priebe, Mark Savill, Ulrich Reininghaus, Til Wykes… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 198 KB

Positive and cost-effectiveness effect o

✍ Mourgues, Charline; Gerbaud, Laurent; Leger, Stéphanie; Auclair, Candy; Peyrol, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 601 KB

Effectiveness and cost-effectiveness of

✍ F Lamers; CCM Jonkers; H Bosma; JPM Diederiks; JThM van Eijk 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 319 KB